ArticleDigestive diseases and sciences2025
Plummer-Vinson Syndrome: A Retrospective Multicenter Study.
Article in Digestive diseases and sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPlummer-Vinson syndrome (PVS) is a rare disorder characterized by post-cricoid dysphagia, iron deficiency anemia (IDA), and upper esophageal web formation. Despite its clinical significance and potential progression to esophageal squamous cell carcinoma (SCC), data on PVS remain limited. This study aims to analyze the demographic, clinical, imaging characteristics, and treatment outcomes of PVS across multiple centers.
methodsA retrospective, multicenter study was conducted across seven high-volume tertiary GI endoscopy centers in Egypt, India, and Iraq between 2021 and 2024. Medical records of consecutive patients diagnosed with PVS, based on the presence of post-cricoid dysphagia, IDA, and upper esophageal web, were reviewed. Clinical data, laboratory investigations, imaging findings, and treatment modalities were analyzed.
resultsA total of 56 patients were included, with a mean age of 41 ± 17 years; 80.5% were female. Post-cricoid dysphagia and IDA were present in all cases, with a mean hemoglobin level of 8.2 ± 1.5 g/dL and serum ferritin of 10.34 ± 5.2 ng/mL. Coeliac disease was the most common associated condition (10.7%). Endoscopic dilation was the primary treatment, with Savary-Gilliard bougie dilators used in 89% of cases. A single dilation session was sufficient in 76.8% of patients. During follow-up, 7.1% developed esophageal SCC/dysplasia. No significant post-dilation complications were observed.
conclusionPVS predominantly affects middle-aged women and is strongly associated with IDA. Endoscopic dilation is an effective treatment, with most patients responding to a single session. Given the potential risk of malignant transformation, close monitoring is essential. Further research is needed to elucidate pathogenesis and optimize management strategies for PVS.
Indexed as
Identifiers
40802140What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.